ProfileGDS4718 / 217158_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 52% 48% 49% 49% 49% 49% 50% 50% 56% 54% 49% 52% 52% 46% 46% 45% 49% 46% 50% 47% 46% 54% 49% 42% 50% 54% 53% 49% 49% 52% 50% 43% 54% 50% 47% 46% 54% 49% 51% 46% 50% 52% 50% 47% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.6019152
GSM549102patient 115, normal, homogenized [OPG study]5.411548
GSM549104patient 119, normal, homogenized [OPG study]5.4351349
GSM549108patient 138, normal, homogenized [OPG study]5.5178149
GSM549119patient 077, normal, homogenized [OPG study]5.4894549
GSM549133patient 032, cancer, homogenized [OPG study]5.4124449
GSM549139patient 042, cancer, homogenized [OPG study]5.5041850
GSM549099patient 107, normal, homogenized [OPG study]5.5003750
GSM549109patient 139, normal, homogenized [OPG study]5.9052956
GSM549110patient 046, normal, homogenized [OPG study]5.7323854
GSM549114patient 063, normal, homogenized [OPG study]5.3882849
GSM549122patient 082, normal, homogenized [OPG study]5.654752
GSM549134patient 033, cancer, homogenized [OPG study]5.6191852
GSM549136patient 036, cancer, homogenized [OPG study]5.2201146
GSM549140patient 044, cancer, homogenized [OPG study]5.2331446
GSM549111patient 047, normal, homogenized [OPG study]5.2030645
GSM549113patient 057, normal, homogenized [OPG study]5.3869649
GSM549132patient 031, cancer, homogenized [OPG study]5.2624146
GSM549137patient 038, cancer, homogenized [OPG study]5.4833850
GSM549142patient 047, cancer, homogenized [OPG study]5.4841347
GSM549100patient 110, normal, homogenized [OPG study]5.3214746
GSM549107patient 135, normal, homogenized [OPG study]5.6948754
GSM549115patient 068, normal, homogenized [OPG study]5.3770249
GSM549116patient 072, normal, homogenized [OPG study]5.0843742
GSM549120patient 078, normal, homogenized [OPG study]5.5216350
GSM549131patient 030, cancer, homogenized [OPG study]5.6897654
GSM549118patient 074, normal, homogenized [OPG study]5.6556853
GSM549129patient 027, cancer, homogenized [OPG study]5.4767949
GSM549123patient 088, normal, homogenized [OPG study]5.4338249
GSM549124patient 006, cancer, homogenized [OPG study]5.6349652
GSM549126patient 015, cancer, homogenized [OPG study]5.4800850
GSM549128patient 025, cancer, homogenized [OPG study]5.1150243
GSM549103patient 117, normal, homogenized [OPG study]5.7664954
GSM549117patient 073, normal, homogenized [OPG study]5.4917650
GSM549138patient 041, cancer, homogenized [OPG study]5.3421747
GSM549141patient 045, cancer, homogenized [OPG study]5.2440246
GSM549130patient 028, cancer, homogenized [OPG study]5.7278654
GSM549101patient 111, normal, homogenized [OPG study]5.5055349
GSM549105patient 128, normal, homogenized [OPG study]5.6036351
GSM549106patient 134, normal, homogenized [OPG study]5.2413446
GSM549112patient 048, normal, homogenized [OPG study]5.4919150
GSM549125patient 011, cancer, homogenized [OPG study]5.6360752
GSM549127patient 024, cancer, homogenized [OPG study]5.5219350
GSM549135patient 035, cancer, homogenized [OPG study]5.3147647